Legal – Annex Policy for the transition of medico-legal drug testing accreditation from ISO 15189 to ISO/IEC 17025 updated

Media Releases May 6, 2021
Legal – Annex Policy for the transition of medico-legal drug testing accreditation from ISO 15189 to ISO/IEC 17025 updated
NATA team

Legal – Annex Policy for the transition of medico-legal drug testing accreditation from ISO 15189 to ISO/IEC 17025 document has been updated on the website.
The document can be downloaded form the ‘Accreditation’ section of the website;
Legal – Annex Policy for the transition of medico-legal drug testing accreditation from ISO 15189 to ISO/IEC 17025

“The NATA Specific Accreditation criteria Legal Annex Policy for the transition of medico-legal drug testing accreditation from ISO 15189 to ISO/IEC 17025 has now been updated to include a transition deadline. As of 1 August 2021, medicolegal drug testing accredited under ISO 15189 will be withdrawn from the scope of accreditation unless the organisation offers medico-legal drug testing as an integral part of their overall pathology services.
Please contact your client coordinator should you require further information.”